What does this make Biotron worth!
New hepatitis C drugs from Merck & Co. and Johnson & Johnson (JNJ) are being sold in France for 22,000 euros ($31,271) and more, a precedent some doctors say may limit access after the medicines are approved throughout Europe.
J&J and Vertex Pharmaceuticals Inc. (VRTX)?s telaprevir costs 22,000 euros under a French program for seriously ill patients for whom there is no other effective treatment on the market, according to patient association SOS Hepatites. Merck & Co. said its boceprevir costs 30,000 euros under the same program.
Merck, J&J?s New Hepatitis C Treatment Fetches $31,000 in France
By Naomi Kresge and Carol Matlack - Apr 5, 2011 6:15 AM GMT+1000 Bloomberg 6/april 2011
- Forums
- ASX - By Stock
- BIT
- new hepatitis c drugs sold in france fr 22,000
new hepatitis c drugs sold in france fr 22,000
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $27.06M |
Open | High | Low | Value | Volume |
3.1¢ | 3.2¢ | 3.1¢ | $2.209K | 70.46K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 230277 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 828 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 230405 | 0.031 |
11 | 594305 | 0.030 |
4 | 1074507 | 0.029 |
5 | 1181573 | 0.028 |
4 | 667000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 828 | 1 |
0.034 | 309907 | 1 |
0.035 | 299839 | 3 |
0.036 | 132784 | 2 |
0.037 | 537816 | 2 |
Last trade - 10.38am 26/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |